Polar Capital Funds plc - Biotechnology Fund Class R EUR Distribution Shares/ IE00B3VXGD32 /
| NAV04/11/2024 | Chg.-0.0200 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 43.1300EUR | -0.05% | paying dividend | Equity Worldwide | Polar Capital ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | - | - | - | - | - | - | - | - | 6.25 | 0.90 | - |
| 2014 | 20.53 | 6.10 | -7.53 | -8.04 | 6.06 | 8.13 | -1.52 | 11.76 | 4.16 | 7.71 | 2.06 | 6.94 | +68.06% |
| 2015 | 13.50 | 5.38 | 7.06 | -8.19 | 11.55 | 1.44 | 5.16 | -9.38 | -12.55 | 10.14 | 5.19 | -2.47 | +25.26% |
| 2016 | -18.00 | -3.38 | -2.43 | 4.67 | 8.71 | -7.46 | 10.36 | -4.16 | 6.08 | -6.00 | 11.15 | -0.57 | -5.12% |
| 2017 | 5.90 | 8.45 | -1.66 | -0.17 | -6.36 | 5.23 | -0.74 | 3.05 | 2.74 | -2.61 | -2.57 | 3.15 | +14.28% |
| 2018 | 8.11 | -2.93 | -1.06 | 1.23 | 8.72 | -0.39 | 2.93 | 3.60 | -2.42 | -9.28 | 3.72 | -9.67 | +0.67% |
| 2019 | 13.68 | 6.21 | 0.09 | -3.29 | -4.15 | 4.19 | 0.33 | -4.47 | -4.59 | 4.39 | 13.61 | 5.14 | +33.09% |
| 2020 | -5.30 | 1.09 | -7.36 | 18.79 | 7.95 | -0.47 | -4.36 | 1.80 | 7.94 | -1.39 | 4.88 | 4.58 | +28.64% |
| 2021 | 4.25 | 0.31 | 0.28 | 3.35 | -2.88 | 3.76 | -2.54 | 9.72 | -3.28 | 1.77 | -4.79 | 2.44 | +12.11% |
| 2022 | -11.03 | -1.87 | 7.31 | -5.49 | -2.04 | 7.55 | 6.19 | 1.65 | -2.05 | 5.04 | -0.19 | -4.67 | -1.44% |
| 2023 | 3.79 | -1.43 | -3.70 | 2.72 | -0.37 | -1.65 | -1.50 | 0.45 | -2.02 | -5.37 | 6.92 | 14.87 | +11.72% |
| 2024 | 3.11 | 5.92 | 0.24 | -6.56 | -0.59 | 6.77 | 5.72 | -1.50 | -5.98 | 4.00 | 1.79 | - | - |
Mois uniques : Dividendes non pris en compte
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 19.03% | 17.52% | 19.93% | 21.41% | 23.63% |
| Ratio de Sharpe | 0.63 | 0.45 | 1.55 | 0.12 | 0.54 |
| Le meilleur mois | +14.87% | +6.77% | +14.87% | +14.87% | +18.79% |
| Le plus défavorable mois | -6.56% | -5.98% | -6.56% | -11.03% | -11.03% |
| Perte maximale | -11.71% | -9.69% | -11.71% | -25.25% | -30.69% |
| Surperformance | +9.54% | - | +17.42% | +29.71% | +78.77% |
Toutes les cotations dans EUR
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Polar Capital Funds plc - Biotec... | reinvestment | 45.2500 | +34.19% | +18.99% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 38.0000 | +29.96% | +16.78% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 49.3200 | +36.13% | +12.35% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 50.8000 | +36.82% | +13.67% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 47.0100 | +35.71% | +11.16% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 43.1300 | +33.78% | +17.75% | |
| Polar Capital Funds plc - Biotec... | paying dividend | 36.2200 | +29.54% | +15.53% |
Performance
| CAD | +12.55% | ||
|---|---|---|---|
| 6 Mois | +5.30% | ||
| 1 An | +33.78% | ||
| 3 Ans | +17.75% | ||
| 5 Ans | +108.16% | ||
| 10 ans | +260.32% | ||
| Depuis le début | +486.01% | ||
| Année | |||
| 2023 | +11.72% | ||
| 2022 | -1.44% | ||
| 2021 | +12.11% | ||
| 2020 | +28.64% | ||
| 2019 | +33.09% | ||
| 2018 | +0.67% | ||
| 2017 | +14.28% | ||
| 2016 | -5.12% | ||
| 2015 | +25.26% | ||
